FSMAX
Price
$100.74
Change
+$0.01 (+0.01%)
Updated
Sep 17 closing price
Net Assets
41.05B
TMAPX
Price
$55.45
Change
+$0.05 (+0.09%)
Updated
Sep 17 closing price
Net Assets
5.35B
Interact to see
Advertisement

FSMAX vs TMAPX

Header iconFSMAX vs TMAPX Comparison
Open Charts FSMAX vs TMAPXBanner chart's image
Fidelity Extended Market Index
Price$100.74
Change+$0.01 (+0.01%)
VolumeN/A
Net Assets41.05B
Touchstone Mid Cap A
Price$55.45
Change+$0.05 (+0.09%)
VolumeN/A
Net Assets5.35B
FSMAX vs TMAPX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FSMAX vs. TMAPX commentary
Sep 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMAX is a Buy and TMAPX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 41B vs. TMAPX (5.35B). FSMAX pays higher dividends than TMAPX: FSMAX (0.44) vs TMAPX (0.04). FSMAX was incepted earlier than TMAPX: FSMAX (14 years) vs TMAPX (18 years). TMAPX (1.17) is less costly to investors than FSMAX (0.04). TMAPX is a more actively managed with annual turnover of: 18.00 vs. FSMAX (9.00). FSMAX has a lower initial minimum investment than TMAPX: FSMAX (0) vs TMAPX (2500). FSMAX annual gain was more profitable for investors over the last year : 18.16 vs. TMAPX (0.02). FSMAX return over 5 years is better than : 60.51 vs. TMAPX (44.26).
FSMAXTMAPXFSMAX / TMAPX
Total Expense Ratio0.041.173%
Annual Report Gross Expense Ratio0.041.173%
Fund Existence14 years18 years-
Gain YTD10.8382.308470%
Front LoadN/A5%-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets41B5.35B767%
Annual Yield % from dividends0.440.041,245%
Returns for 1 year18.160.0293,817%
Returns for 3 years57.1534.29167%
Returns for 5 years60.5144.26137%
Returns for 10 years103.14132.2178%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ISCSX16.64N/A
N/A
VY® Columbia Contrarian Core S
PRDGX84.33N/A
N/A
T. Rowe Price Dividend Growth
TLVCX16.28N/A
N/A
Timothy Plan Large/Mid Cap Value C
CSGZX94.55N/A
N/A
Columbia Seligman Global Tech Inst
GGCPX16.07N/A
N/A
Goldman Sachs International T/M Eq P